CROs/Service Providers

The Hamner Institutes for Health Sciences partners with QPS Holdings

Wednesday, February 20, 2013 10:26 AM

The Hamner Institutes for Health Sciences, a nonprofit research organization focused on translational safety sciences, and QPS Holdings, a Newark, Delaware-based CRO, have announced the launch of QPS Hepatic Biosciences, a center of excellence for cell based research and services. 

More... »

Quintiles files registration statement for IPO

Friday, February 15, 2013 05:03 PM

Quintiles Transnational Holdings has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

More... »

Cromsource further expands Polish operations

Friday, February 15, 2013 11:17 AM

Cromsource, an international full service CRO, has opened of a new office building in Warsaw, Poland, and has completed moving key company services to the new location.

More... »

WCCT Global successfully completes enrollment in ethnobridging study

Monday, February 11, 2013 02:37 PM

WCCT Global, a global CRO supporting phase I-IV bio-pharmaceutical and device development, announced the success of their specialized recruitment methods for ethnobridging studies.

More... »

PPD adds new central laboratory services

Monday, February 11, 2013 10:57 AM

Global CRO Pharmaceutical Product Development (PPD) has expanded its testing capabilities at its Brussels and Singapore labs, offering clients additional microbiology, peripheral blood mononuclear cell and molecular pathology services.

More... »

Cardiome selects Quintiles to manage global regulatory affairs for Brinavess

Monday, February 11, 2013 10:22 AM

Biopharmaceutical company Cardiome Pharma has selected Quintiles, a global provider of biopharmaceutical services, to provide comprehensive post-marketing lifecycle safety and global regulatory affairs services for Brinavess (vernakalant intravenous). Quintiles will begin providing these services effective immediately as Cardiome continues to prepare for the anticipated transfer of Brinavess from Merck to Cardiome.

More... »

Icon, DIA to deliver new educational product

Monday, February 11, 2013 09:53 AM

Icon,a global provider of outsourced development, has formed a collaboration with DIA, a neutral, global, professional, member-driven association of nearly 18,000 pharmaceutical, biotechnology, and medical device professionals, to deliver the first solution-provider webinar, which offers free access to knowledge and innovative solutions to overcome some of the key challenges in medical product development.

More... »

Exco InTouch joins C-Path ePRO Consortium

Wednesday, February 6, 2013 12:10 PM

Exco InTouch, a provider of patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, a program run by nonprofit Critical Path Institute (C-Path), which strives to enhance the quality of patient reported outcomes (PRO) in the evaluation of new pharmaceuticals. 

More... »

Janssen Labs at San Diego adds concept lab, open collaboration space

Wednesday, February 6, 2013 10:43 AM

Janssen Labs at San Diego, part of Janssen Research & Development, is adding a concept lab and an open collaboration space, just one year after opening.

More... »

MicroConstants China to provide site management services to Chinese hospital

Monday, February 4, 2013 03:39 PM

CRO MicroConstants China, which conducts preclinical pharmacokinetic studies, early-stage clinical trials and regulated bioanalysis in China, has signed a strategic collaboration agreement with the clinical research center of the No. 307 Hospital of People's Liberation Army to provide site management services.

More... »